CSU TB lab searching for promising drugs
Dr. Anne Lenaerts (left) has taken on more of the work as one of the lab's principals, Dr. Ian Orme, prepares to eventually retire.
They come to Colorado State University where, at state-of-the-art facilities in several locations, perhaps the premier tuberculosis research team in the world is to be found. And while breakthroughs come slowly in fighting this ancient disease, those who work in the Mycobacteria Research Laboratories are in a hurry. Tuberculosis, once in decline, has come roaring back around the world as HIV has spread.
Today, the MRL boasts a staff of 168. Its visionary founder, Dr. Patrick Brennan, laid the groundwork for the research group 25 years ago, intending to create an internationally recognized center for the study of pathogens that cause diseases like tuberculosis and leprosy. Brennan built his team by going after the top researchers in the field.
TB is caused by various strains of pathogens that cause often fatal diseases. While generally associated with the lungs, it can attack other parts of the body. It has been estimated that a third of the world's population has been exposed
More breaking news...
Inviragen’s sale this month likely to boost investor interest in NoCo bioscience firms
Myth-information plagues health-care reform
In-Situ’s data goes with the flow




















